QuidelOrtho Corporation (QDEL)

NASDAQ: QDEL · Real-Time Price · USD

14.30

-0.79 (-5.24%)

At close: Aug 14, 2026, 4:00 PM EDT

14.33

+0.03 (0.21%)

After-hours: Aug 14, 2026, 7:49 PM EDT

QuidelOrtho Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022
Revenue	2,674	2,730	2,783	2,998	3,266	1,699
Revenue Growth	-2.46%	-1.89%	-7.17%	-8.21%	92.28%	2.22%
Gross Profit	1,200	1,278	1,287	1,497	1,936	1,278
Operating Income	37.1	123.6	47	257	994.8	915.6
Net Income	-1,048	-1,132	-2,052	-10.1	548.7	704.2
Earnings Per Share	-15.40	-16.69	-30.54	-0.15	9.56	16.43
EPS Growth	-	-	-	-	-41.81%	-11.64%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022
Labs	1,499	1,506	1,427	1,425	820.2	44.8
Immunohematology	555.5	543.8	522	512.4	296.8	-
Donor Screening	38.3	52.6	115.1	136.1	97	-
Point of Care	558.7	601.6	694.6	892.2	1,955	1,453
Molecular Diagnostics	22.7	26.5	24	31.7	96.7	200.5
Revenue (Total)	2,674	2,730	2,783	2,998	3,266	1,699

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022
Cash & Investments	123.4	170.1	99.6	174.9	381.9	866.4
Total Debt	3,076	2,854	2,681	2,621	2,851	139.3
Net Cash (Debt)	-2,952	-2,684	-2,582	-2,446	-2,469	727.1
Net Cash Growth	-	-	-	-	-	90.62%
Net Cash Per Share	-43.35	-39.58	-38.42	-36.62	-43.02	16.95

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022
Operating Cash Flow	-57.2	105.2	83	280.2	885.3	805.9
Capital Expenditures	-154	-188.2	-195.1	-209.3	-140.9	-292.8
Free Cash Flow	-211.2	-83	-112.1	70.9	744.4	513.1
Free Cash Flow Growth	-	-	-	-90.48%	45.08%	-9.15%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022
Gross Margin	44.86%	46.81%	46.23%	49.94%	59.28%	75.26%
Operating Margin	1.39%	4.53%	1.69%	8.57%	30.46%	53.90%
Pretax Margin	-38.52%	-40.57%	-76.59%	-0.97%	22.53%	53.00%
Profit Margin	-39.20%	-41.45%	-73.74%	-0.34%	16.80%	41.46%
FCF Margin	-7.90%	-3.04%	-4.03%	2.37%	22.79%	30.21%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 16, 2026	Dec '25 Dec 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022
PE Ratio	-	-	-	-	10.31	7.99
Forward PE	16.07	13.89	21.58	14.60	17.67	14.83
P/FCF Ratio	-	-	-	69.46	7.60	10.96
PS Ratio	0.37	0.73	1.07	1.64	1.73	3.31